What is the success rate of CYTOTRON treatment in Osteoarthritis and Cancer?
First of all, it depends on how you define ‘success rate’. Success can be viewed from both subjective and objective side. Subjective side is how the patient feels and his general quality of life after the treatment and the objective side is the actual physical measurements that determine the end point of our research. In case of osteoarthritis, the subjective success is about 85% and the objective success is about 98%; this means 85% of the 202 patients treated during the phase II clinical trials were pain free, with increased movement of their treated joints and could walk longer distance, climb stairs and drive. The objective success rate is 98%, as we could achieve our end-point for up to 98% of the patients treated. In case of terminal cancer patients, the success rate means a little different from others. Terminal cancer patients have a few weeks or months to live. So, in research involving terminal cancer patients, a one-year survival rate is taken. Out of the treated terminal ca
